Search Results
Active Filters
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Jan 14, 2026, 10:52 ET Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff
Oncolytics Biotech Inc. (NASDAQ: ONCY), Nurix Therapeutics (NASDAQ: NRIX), Erasca (NASDAQ: ERAS), Foghorn Therapeutics (NASDAQ: FHTX), and ORIC Pharmaceuticals (NASDAQ: ORIC).
More news about: Equity Insider
Dec 11, 2025, 10:17 ET Platform Technologies Drive $211B Surge in Precision Cancer Treatment
mechanisms, creating momentum for GT Biopharma, Inc. (NASDAQ: GTBP), Erasca, Inc. (NASDAQ: ERAS), Foghorn Therapeutics Inc. (NASDAQ: FHTX), OmniAb, Inc. (NASDAQ: OABI), and Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX).
More news about: Equity Insider